MENU
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Fate Therapeutics (FATE) Earnings Date & Reports

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

FATE is expected to report earnings to fall 10.55% to -39 cents per share on April 30

Fate Therapeutics FATE Stock Earnings Reports
Q1'25
Est.
$-0.39
Q4'24
Est.
$-0.44
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.01
The last earnings report on March 05 showed earnings per share of -43 cents, meeting the estimate of -43 cents. With 774.84K shares outstanding, the current market capitalization sits at 88.24M.
View a ticker or compare two or three
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com